Viewing Study NCT00086892


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT00086892
Status: COMPLETED
Last Update Posted: 2014-02-14
First Post: 2004-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent ovarian epithelial cancer View
None primary peritoneal cavity cancer View